Key points are not available for this paper at this time.
Enhanced phagocytosis in OCI-Ly3 cells is achieved when BMS-986351 is combined with rituximab.
Chan et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: